Literature DB >> 29393503

Circular RNAs: Characteristics, function, and role in human cancer.

Shuo Chen1,2,3, Yang Zhao1,2,4.   

Abstract

Circular RNAs (circRNAs) are universal and diverse endogenous noncoding RNAs (ncRNAs) that are widely found in eukaryotic cells. They form a covalently closed, continuous stable loop structure without 3' or 5' tails, which are different from linear RNAs. As new members of the ncRNAs, circRNAs' formation, function, and mechanism are attracting increased research attention. CircRNAs play important roles in all kinds of cancer and may be potential novel biomarkers and therapeutic targets for cancer treatment through their function as microRNA (miRNA) molecular "sponges", RNA-binding protein (RBP) sponges, protein translators, and gene transcription regulators. In this review, we introduce the formation and function of circRNAs, and summarize the biological effects of circRNA in tumorigenesis and progression, providing evidence for the potential use of circRNAs in the diagnosis and clinical treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29393503     DOI: 10.14670/HH-11-969

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  16 in total

Review 1.  Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy.

Authors:  Amir Ajoolabady; Daolin Tang; Guido Kroemer; Jun Ren
Journal:  Br J Cancer       Date:  2022-10-13       Impact factor: 9.075

2.  Hsa_circ_0103232 promotes melanoma cells proliferation and invasion via targeting miR-661/RAB3D.

Authors:  Xing Lin; Liang Zhong; Nian Wang; Xuan Chu; Beizhong Liu
Journal:  Cell Cycle       Date:  2022-05-13       Impact factor: 5.173

3.  Lidocaine Suppresses Gastric Cancer Development Through Circ_ANO5/miR-21-5p/LIFR Axis.

Authors:  Enjian Guan; Hongrong Liu; Ning Xu
Journal:  Dig Dis Sci       Date:  2021-05-29       Impact factor: 3.487

Review 4.  Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma.

Authors:  Zhixia Zhou; Zhan Wang; Jie Gao; Zhijuan Lin; Yin Wang; Peipei Shan; Mengkun Li; Tingting Zhou; Peifeng Li
Journal:  Mol Ther Oncolytics       Date:  2022-03-16       Impact factor: 6.311

Review 5.  Circular RNAs in immune responses and immune diseases.

Authors:  Xu Chen; Tian Yang; Wei Wang; Wenjin Xi; Tianze Zhang; Qi Li; Angang Yang; Tao Wang
Journal:  Theranostics       Date:  2019-01-01       Impact factor: 11.556

6.  Integrated analysis of circular RNA-associated ceRNA network in cervical cancer: Observational Study.

Authors:  Jun Gong; Hui Jiang; Chang Shu; Mei-Qin Hu; Yan Huang; Qin Liu; Rong-Feng Li; Yin-Zhi Wei
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

7.  The Pharmacological Effects of Spatholobi Caulis Tannin in Cervical Cancer and Its Precise Therapeutic Effect on Related circRNA.

Authors:  Nijia Wang; Jiayi Wang; Xiansheng Meng; Tianjiao Li; Shuai Wang; Yongrui Bao
Journal:  Mol Ther Oncolytics       Date:  2019-05-17       Impact factor: 7.200

8.  Circular RNA hsa_circ_0078607 suppresses ovarian cancer progression by regulating miR-518a-5p/Fas signaling pathway.

Authors:  Nan Zhang; Yue Jin; Qiubo Hu; Shanshan Cheng; Chao Wang; Zhiyou Yang; Yu Wang
Journal:  J Ovarian Res       Date:  2020-06-05       Impact factor: 4.234

9.  CircUBAP2-mediated competing endogenous RNA network modulates tumorigenesis in pancreatic adenocarcinoma.

Authors:  Rongjie Zhao; Junjie Ni; Si Lu; Sujing Jiang; Liangkun You; Hao Liu; Jiawei Shou; Chongya Zhai; Wei Zhang; Shengpeng Shao; Xinmei Yang; Hongming Pan; Weidong Han
Journal:  Aging (Albany NY)       Date:  2019-10-04       Impact factor: 5.682

10.  CircRNA Expression Profiles and the Potential Role of CircZFP644 in Mice With Severe Acute Pancreatitis via Sponging miR-21-3p.

Authors:  Yi Yang; Jiandong Ren; Qilin Huang; Jun Wu; Xiaohui Yuan; Wen Jiang; Yi Wen; Lijun Tang; Hongyu Sun
Journal:  Front Genet       Date:  2020-03-12       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.